Biosketch
Eric J. Evans is an active member of the early-stage investor community in Boston. He sits on the Executive Committee of Mass Medical Angels and on the Screening Committee of Launchpad Ventures. Since many early-stage deals are now syndicated, he also maintains relationships with Hub Investment Group, Sky Ventures, Boston Harbor Angels and Cherrystone, among others. He has served as CEO for several biomedical companies, including Targeted Cell Therapies, Abazyme, Lumos Catheter Systems, Mulleris Therapeutics and Follica Biosciences. He began his career at Procter & Gamble and at the Boston Consulting Group. Evans holds a master's degree in finance and public policy from the Wharton School at the University of Pennsylvania, and a bachelor's degree in nuclear physics from Brown University. Currently he is assisting NIH (National Institutes of Health) with their RADx (Rapid Acceleration of Diagnostics) effort against Covid-19.
